BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26874285)

  • 1. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
    Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
    Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable intratumoral hydrogel as 5-fluorouracil drug depot.
    Seo HW; Kim DY; Kwon DY; Kwon JS; Jin LM; Lee B; Kim JH; Min BH; Kim MS
    Biomaterials; 2013 Apr; 34(11):2748-57. PubMed ID: 23343635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of doxorubicin-containing thermosensitive hydrogels incorporated with docetaxel-loaded mixed micelles enhances local cancer therapy.
    Sheu MT; Jhan HJ; Su CY; Chen LC; Chang CE; Liu DZ; Ho HO
    Colloids Surf B Biointerfaces; 2016 Jul; 143():260-270. PubMed ID: 27022865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer.
    Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS
    Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
    Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
    J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
    Nittayacharn P; Nasongkla N
    J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel injectable phospholipid gel co-loaded with doxorubicin and bromotetrandrine for resistant breast cancer treatment by intratumoral injection.
    Luo JW; Zhang T; Zhang Q; Cao X; Zeng X; Fu Y; Zhang ZR; Gong T
    Colloids Surf B Biointerfaces; 2016 Apr; 140():538-547. PubMed ID: 26628333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
    Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
    Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs.
    Yang C; Liu SQ; Venkataraman S; Gao SJ; Ke X; Chia XT; Hedrick JL; Yang YY
    J Control Release; 2015 Jun; 208():93-105. PubMed ID: 25813888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin.
    Liu H; Xu H; Wang Y; He Z; Li S
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1031-8. PubMed ID: 22794192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ injection of phenylboronic acid based low molecular weight gels for efficient chemotherapy.
    Gao W; Liang Y; Peng X; Hu Y; Zhang L; Wu H; He B
    Biomaterials; 2016 Oct; 105():1-11. PubMed ID: 27497056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates.
    Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A
    J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent.
    Liu J; Chi D; Pan S; Zhao L; Wang X; Wang D; Wang Y
    Int J Pharm; 2019 Feb; 557():264-272. PubMed ID: 30599233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy.
    Han R; Sun Y; Kang C; Sun H; Wei W
    J Drug Target; 2017 Feb; 25(2):140-148. PubMed ID: 27356094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic therapeutic effects of Schiff's base cross-linked injectable hydrogels for local co-delivery of metformin and 5-fluorouracil in a mouse colon carcinoma model.
    Wu X; He C; Wu Y; Chen X
    Biomaterials; 2016 Jan; 75():148-162. PubMed ID: 26497429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.
    Chun C; Lee SM; Kim CW; Hong KY; Kim SY; Yang HK; Song SC
    Biomaterials; 2009 Sep; 30(27):4752-62. PubMed ID: 19520429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged local delivery of doxorubicin to cancer cells using lipid liquid crystalline system.
    Karimi M; Kamali H; Fakhrmohammadi S; Khezri E; Malaekeh-Nikouei B; Mohammadi M
    Int J Pharm; 2023 May; 639():122947. PubMed ID: 37044227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.